WO2010006296A3 - New avian bornavirus - Google Patents

New avian bornavirus Download PDF

Info

Publication number
WO2010006296A3
WO2010006296A3 PCT/US2009/050300 US2009050300W WO2010006296A3 WO 2010006296 A3 WO2010006296 A3 WO 2010006296A3 US 2009050300 W US2009050300 W US 2009050300W WO 2010006296 A3 WO2010006296 A3 WO 2010006296A3
Authority
WO
WIPO (PCT)
Prior art keywords
bornavirus
methods
new avian
infection
avian bornavirus
Prior art date
Application number
PCT/US2009/050300
Other languages
French (fr)
Other versions
WO2010006296A2 (en
Inventor
Joseph Derisi
Don Ganem
Kael Fischer
Amy Kistler
Peter Skewes-Cox
Katherine Sober
Charles Chiu
Alex Greninger
Scott B. Karlene
Susan Clubb
Ady Gancz
Avishai Lublin
Original Assignee
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California
Publication of WO2010006296A2 publication Critical patent/WO2010006296A2/en
Publication of WO2010006296A3 publication Critical patent/WO2010006296A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention relates to the discovery of a new avian bornavirus as the causative agent for psittacine proventricular dilation disease, methods of detecting the bornavirus and diagnosing bornavirus infection, methods of treating or preventing bornavirus infection, and methods for identifying anti-bornaviral compounds.
PCT/US2009/050300 2008-07-11 2009-07-10 New avian bornavirus WO2010006296A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13463008P 2008-07-11 2008-07-11
US61/134,630 2008-07-11
US22440709P 2009-07-09 2009-07-09
US61/224,407 2009-07-09

Publications (2)

Publication Number Publication Date
WO2010006296A2 WO2010006296A2 (en) 2010-01-14
WO2010006296A3 true WO2010006296A3 (en) 2010-03-04

Family

ID=41400615

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/050300 WO2010006296A2 (en) 2008-07-11 2009-07-10 New avian bornavirus

Country Status (1)

Country Link
WO (1) WO2010006296A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10321920B2 (en) 2015-11-06 2019-06-18 Mcginley Engineered Solutions, Llc Measurement system for use with surgical burr instrument
JP6944692B2 (en) 2017-03-14 2021-10-06 国立大学法人京都大学 Bornavirus vector and its use

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021020A2 (en) * 1995-01-06 1996-07-11 The Regents Of The University Of California Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
WO2007130519A2 (en) * 2006-05-02 2007-11-15 Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Viral nucleic acid microarray and method of use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021020A2 (en) * 1995-01-06 1996-07-11 The Regents Of The University Of California Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
WO2007130519A2 (en) * 2006-05-02 2007-11-15 Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Viral nucleic acid microarray and method of use

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BERG M ET AL: "Wild birds as a possible natural reservoir of Borna disease virus", EPIDEMIOLOGY AND INFECTION, vol. 127, no. 1, August 2001 (2001-08-01), pages 173 - 178, XP008116430, ISSN: 0950-2688 *
DATABASE EMBL E.B.I. Hinxton U.K.; 10 July 2008 (2008-07-10), BAPTISTA C S ET AL: "Viral microarray oligonucleotide sequence SEQ ID NO 438.", XP002561217, Database accession no. AQY00336 *
DATABASE EMBL E.B.I. Hinxton U.K.; 18 December 2003 (2003-12-18), TELERMAN A ET AL: "Tumour suppression/reversion associated nucleotide nr.5068", XP002561216, Database accession no. ADB44745 *
DATABASE EMBL E.B.I. Hinxton U.K.; 4 February 2002 (2002-02-04), BOULESTIN A. ET AL.: "Hepatitis C virus from patient R3 pretreatment 1 polyprotein gene glycoprotein E2 phosphorylation homology domain region, partial cds.", XP002561215, Database accession no. AF466512 *
DONELEY R ET AL: "Proventricular dilatation disease: an emerging exotic disease of parrots in Australia", AUSTRALIAN VETERINARY JOURNAL, vol. 85, no. 3, March 2007 (2007-03-01), pages 119 - 123, XP002561222, ISSN: 0005-0423 *
HONKAVUORI K ET AL: "Novel Borna Virus in Psittacine Birds with Proventricular Dilatation Disease", EMERGING INFECTIOUS DISEASES, vol. 14, no. 12, December 2008 (2008-12-01), pages 1883 - 1886, XP002561220, ISSN: 1080-6040 *
KISTLER AMY L ET AL: "Recovery of divergent avian bornaviruses from cases of proventricular dilatation disease: identification of a candidate etiologic agent", 31 July 2008, VIROLOGY JOURNAL, BIOMED CENTRAL, LONDON, GB, PAGE(S) 1 - 15, ISSN: 1743-422X, XP002561218 *
RINDER M ET AL: "Broad Tissue and Cell Tropism of Avian Bornavirus in Parrots with Proventricular Dilatation Disease", JOURNAL OF VIROLOGY, vol. 83, no. 11, June 2009 (2009-06-01), pages 5401 - 5407, XP002561219, ISSN: 0022-538X *

Also Published As

Publication number Publication date
WO2010006296A2 (en) 2010-01-14

Similar Documents

Publication Publication Date Title
WO2008051416A3 (en) Compounds that inhibit the activity of hsp90 for treating infections
WO2009051670A3 (en) Oxylipin compounds for the treatment of ophthalmic conditions
WO2008153692A3 (en) Microrna expression profiling of cerebrospinal fluid
WO2010062377A3 (en) Methods and compositions for the detection and treatment of preeclampsia
WO2008070129A3 (en) Compositions and methods for the treatment of inflammatory disease
WO2009026166A3 (en) Antiinfective flavonol compounds and methods of use thereof
WO2006113942A3 (en) Method of inhibiting cathepsin activity
AP2010005480A0 (en) Small molecule inhibitors for the treatment or prevention of denque virus infection.
WO2007047408A3 (en) Promac signature application
WO2008153705A3 (en) Methods of treating, diagnosing and detecting fgf21-associated disorders
NO20092711L (en) Methods for using cyclopamine analogues
WO2007059230A3 (en) Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
WO2009111633A3 (en) Mercaptan and seleno-mercaptan compounds and methods of using them
ZA201101814B (en) Prevention, treatment and diagnosis of p.gingivalis infection
WO2006089871A3 (en) Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
WO2006076370A3 (en) Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions
BRPI0718850A2 (en) METHODS OF TREATING, DIAGNOSING OR DETECTION CANCER
WO2009074247A8 (en) Novel 2-aryl-thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
WO2009120712A3 (en) Compositions and methods for diagnosing and treating melanoma
BRPI0717741A2 (en) PREPARATION METHODS, METHOD OF PREPARATION, SUBSTITUTED SULFONIL COMPOUND REDUCTION METHOD, PHARMACEUTICAL COMPOSITION TREATMENT OR DISEASE PREVENTION
WO2010123959A3 (en) 2,5-disubstituted arylsulfonamide ccr3 antagonists
EA200900261A1 (en) USE OF ESCIN
WO2008067559A3 (en) Methods for treating and diagnosing fibrotic and fibroproliferative diseases
BRPI0815003A2 (en) USE OF A COMPOUND, COMPOSITIONS, COMPOUNDS, USE OF THE SAME, METHOD OF TREATMENT, IMPROVEMENT OR PROPHYLAXIS OF SYMPTOMS OF AN INFLAMMATORY DISORDER.
BRPI0910884A2 (en) immunogenic composition, method for treating or preventing staphylococcal infection or disease, and use of an immunogenic composition.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09790297

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09790297

Country of ref document: EP

Kind code of ref document: A2